000			01452cam a2200397 a 4500
999			_c238 _d238
001			739588
003			MACHS
005			20210413150441.0
008			930812s1994 xxc|||| |||| 00||0|eng
010			_a93-30511
020			_a9780919839410 (pbk.)
020			_a091983941X (pbk.)
040			_aDNLM _cDNLM
041	0	9	_aeng
050			_aRC944 _bG67 1994
060	0	0	_a1995 B-874
060	1	0	_aWI 900 _bR745 1994
245	0	4	_aThe Role of piperacillin/tazobactam in the treatment of intra-abdominal infections / _ceditors, Sherwood L. Gorbach, Carl Erik Nord.
260			_aMontreal ; _aChicago : _bPharmaLibri, _c1994.
300			_a123 p. : _bill.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
490	1		_aPharmanual
504			_aIncludes bibliographical references.
650	1	2	_aAbdomen _0https://id.nlm.nih.gov/mesh/D000005
650	2	2	_aBacterial Infections _xdrug therapy _0https://id.nlm.nih.gov/mesh/D001424Q000188
650	2	2	_aDrug Therapy, Combination _0https://id.nlm.nih.gov/mesh/D004359
650	2	2	_aPenicillanic Acid _xtherapeutic use _0https://id.nlm.nih.gov/mesh/D010397Q000627
650	2	2	_aPiperacillin _xtherapeutic use _0https://id.nlm.nih.gov/mesh/D010878Q000627
700	1		_aGorbach, Sherwood L., _d1934-
700	1		_aNord, Carl Erik.
830		0	_aPharmanual (Chicago, Ill.)
942			_2lcc _cBK